Oh it hurts so good! Mechanism of action for leronlimab being recognized for what it is.... game changing! How many indications will pharma want to get into with CytoDyn? Think about it. Dozens. I SEE THREE FINGERS AND A THUMB INCHIING INTO THE SCENE!!
WONDER HOW MANY BUY STOPS WERE HIT JUST THIS MORNING???? HOW MANY GOT TAKEN OUT BY BROKERS?
YOU AIN'T SEEN NOTHING YET. BRING ON THE NEWS!
DOES ANYONE SMELL TOAST BURNING. LAUGHING REALLY LAUGHING.
GO CYTODYN, GO INTERNATIONAL!!!
IS THE HUMONGOUS EXPANSION IN SAMSUNG CITY S. KOREA FOR LERONLIMAB ??
Germania1, I can agree to some extent but to say it's over now may be a bit of an overstatement. The shorting crowd will still continue to use the tools at their disposal until such time as MAJOR news occurs, such as a merger with a major, a buyout or FDA approval. When REAL money enters the picture (revenue) then you tend to see less games played as the shorts move on to easier pickings. There's plenty out there. They don't need to fight a losing game once revenue enters the picture for the targeted company.